Search
for
Sort by
Research 931–960 of 1000+
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Alopecia and Mental Health: Psychosocial Burden, Neuroendocrine Mechanisms, and Therapeutic Implications
- Alopecia and Mental Health: Psychosocial Burden, Neuroendocrine Mechanisms, and Therapeutic Implications
- Ann Robinson’s research reviews —12 May 2022
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- Alopecia Areata: Current and Emerging Therapies
- Advances in the mechanism and new therapies of alopecia areata
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- <i>IKZF1</i> and Ikaros Overexpression Results in Alopecia Areata‐Like Phenotype in Mice
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Responses to Tetanus and Meningococcal Vaccines in Patients with Alopecia Areata Treated with Ritlecitinib
- Effects of the RV3466F lotion on female telogen effluvium: Results from a 16 week, multi-centric, controlled, randomized trial
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Local Corticosteroids for Alopecia Areata: A Narrative Review
- A Bibliometric Analysis of Alopecia Areata Literature over the Past 50 Years.
- Evidence Synthesis Gone Awry: The Perils of Aggregating Ineffective or Unsafe Doses in Alopecia Areata Reviews
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- New treatment modalities of alopecia areata
- Androgenetic Alopecia: Therapy Update
- Factors affecting the development of alopecia areata in children
- Treatments for alopecia areata: a network meta-analysis
- K <sub>ATP</sub> Channels and Cardiovascular Disease
- Alopecia areata
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- Clinical Outcomes of Ritlecitinib in Treatment-Refractory Alopecia Areata: A Single-Center Real-World Study
- 546 Gene expression signatures and ALADIN score correlates with response of alopecia areata patients to treatment with JAK inhibitors